GLP-1 receptors can be found in many locations in the body, including the gut, brain, and heart
In case non-inferiority is reached at the end of the study, a statistical testing for superiority (cardiovascular benefit of the tested novel substance) can be performed
All of this evidence is still quite uncertain and beyond these three medications, scientists dont know exactly how GLP-1s might interfere with other drugs
declares associations to Abbott, ADOC Pharma, Alkaloid, AstraZeneca, Bayer, Boehringer-Ingelheim, Berlin-Chemie, Eli Lilly, Galenika, Krka, Merck, Novo Nordisk, PharmaSwiss, Sanofi-Aventis, Servier, Viatris, and Wrwag Pharma
Angiotensin II Stimulates NHE3 Activity by Exocytic Insertion of the Transporter: Role of PI 3-Kinase